A phase Ib/II trial with expansion of patients at the MTD trial of olaparib plus weekly (metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Saul E. Rivkin, Desiree Iriarte, Heather Sloan, Cara Wiseman, James Moon, Gary E. Goodman, Amy Bondurant, Daniel Veljovich, Peter Y. Z. Jiang, Tanya A. Wahl, Chirag Shah, Charles Drescher, Henry G. Kaplan, William A. Peters, Erin Ellis, Mehmet F. Fer, Min S. Park, Eileen Johnston
Institutions: Fred Hutch Cancer Center, Swedish Medical Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4253247138